Edition:
United Kingdom

Catabasis Pharmaceuticals Inc (CATB.OQ)

CATB.OQ on NASDAQ Stock Exchange Global Market

7.00USD
18 Mar 2019
Change (% chg)

$0.29 (+4.32%)
Prev Close
$6.71
Open
$7.05
Day's High
$7.30
Day's Low
$6.85
Volume
53,974
Avg. Vol
37,464
52-wk High
$20.70
52-wk Low
$3.60

Chart for

About

Catabasis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics based on its Safely Metabolized And Rationally Targeted (SMART), a linker drug discovery platform. The SMART linker drug discovery platform enables to engineer... (more)

Overall

Beta: --
Market Cap(Mil.): $55.98
Shares Outstanding(Mil.): 22.48
Dividend: --
Yield (%): --

Financials

  CATB.OQ Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -1.74 -- --
ROI: -107.14 8.89 13.82
ROE: -117.90 10.00 15.25

Earnings vs. Estimates